Price, one year
Price range
- Open
- ₹330.30
- High
- ₹330.90
- Low
- ₹318.40
- Previous close
- ₹330.30
- Volume
- 34.7 L
- Market cap
- ₹52,721 Cr
Key statistics
Results to 30 Jun 2026 · Consolidated- P/E (TTM)
- 95.1
- Price to book
- 1.5
- Return on equity
- 1.5%
- EPS (TTM)
- ₹3.40
- Book value / share
- ₹208.82
- Debt to equity
- 0.40
- Revenue (TTM)
- ₹17,321 Cr
- Net profit (TTM)
- ₹495 Cr
- Sales growth, YoY
- +10.0%
- Profit growth, YoY
- +349.4%
- Operating margin
- 20.4%
- Net margin
- 2.9%
- Sales CAGR, 3 years
- +14.8%
- Profit CAGR, 3 years
- −5.9%
- Promoter holding
- 44.68%
- Promoter shares pledged
- 0.00%
Shareholding pattern
% of shares| Holder | Jun 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|
| Promoters | 44.68 | 44.68 | 44.68 |
| Foreign institutions | 8.16 | 8.14 | 8.64 |
| Domestic institutions | 23.37 | 23.38 | 29.30 |
| Mutual funds | 15.49 | 15.47 | 22.08 |
| Retail and others | 10.16 | 10.26 | 10.19 |
Futures and options
23 Oct 2026- Lot size
- 2,500
- Put-call ratio (OI)
- 0.64
- Max pain
- ₹355.00
- Highest call OI strike
- 355.00
- Highest put OI strike
- 360.00
- ATM implied volatility
- 30.8% IV rank 48
- Futures basis
- −0.17%
- Rollover
- 55.0%
Futures open interest, last sessions
| Date | Build-up | Price | OI change |
|---|---|---|---|
| 23 Oct | Long unwinding | −2.33% | −1.51% |
| 22 Oct | Short buildup | −0.77% | +0.01% |
| 21 Oct | Long unwinding | −2.32% | −0.97% |
| 19 Oct | Long unwinding | −2.24% | −0.07% |
| 16 Oct | Long unwinding | −0.81% | −0.13% |
Option figures are for the 27 Oct 2026 expiry.
Results and announcements
Latest results (quarter to 30 Jun 2026) filed 5 Aug 2026.
Peers in Healthcare
All Healthcare stocks| Company | Price | Change |
|---|---|---|
| Sun Pharmaceutical IndustriesSUNPHARMA | ₹1,748.00 | −0.57% |
| Divi's LaboratoriesDIVISLAB | ₹8,950.00 | −2.31% |
| Torrent PharmaceuticalsTORNTPHARM | ₹4,524.40 | −1.97% |
| Zydus LifesciencesZYDUSLIFE | ₹1,129.40 | −0.49% |
| Apollo Hospitals EnterpriseAPOLLOHOSP | ₹7,730.00 | +1.65% |
| CiplaCIPLA | ₹1,338.00 | +0.53% |
| Laurus LabsLAURUSLABS | ₹1,970.00 | −1.62% |
| Dr. Reddy's LaboratoriesDRREDDY | ₹1,229.50 | −0.77% |
| Mankind PharmaMANKIND | ₹2,212.60 | −2.77% |
| Aurobindo PharmaAUROPHARMA | ₹1,571.70 | −2.43% |
Frequently asked questions
What is the share price of Biocon today?
Biocon (NSE: BIOCON) was at ₹323.50 on 23 Oct 2026, a change of −2.06% from the previous close.
What are the 52-week high and low of Biocon?
Over the last 52 weeks Biocon traded between ₹318.40 and ₹447.15 (daily highs and lows on NSE on 23 Oct 2026).
What is the market capitalisation of Biocon?
About ₹52,721 Cr at the latest price, with a P/E of 95.1, a price-to-book of 1.5, a return on equity of 1.5%. Ratios use the company's latest reported results.
Who owns Biocon shares?
According to the shareholding pattern filed with the exchange at the end of the quarter to 30 Sep 2026, promoters held 44.68%, foreign institutions 8.64%, domestic institutions 29.30%.
Is Biocon traded in futures and options?
Yes, BIOCON is in NSE's futures and options segment. The lot size is 2,500 shares.
Which sector and indices does Biocon belong to?
NSE classifies Biocon under Healthcare; it is a member of Nifty 500.
Follow Biocon with research you can verify. Add it to a watchlist, see screens and charts, and get calls from SEBI-registered research analysts with recorded track records.
Start free trial